Medical Communications

Showing 15 posts of 6402 posts found.

ian_hudson

MHRA Chief to step down in 2019

November 21, 2018 Medical Communications, Research and Development MHRA, UK, brexit, pharma

The Medicines and Healthcare products Regulatory Agency (MHRA), the regulator responsible for the efficacy and safety of medicines in the …
arnaud_breabout

Mundipharma name GSK veteran as new Senior Vice President & CFO

November 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, Mundipharma, arnaud breabout, cfo, svp, wsenior vice president

The Mundipharma network today confirmed the appointment of Arnaud Breabout, to the position of Senior Vice President & Chief Financial …
david_wehner

Alector strengthens board with three appointments including Facebook CFO David Wehner

November 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Facebook’s Chief Financial Officer (CFO) David Wehner has joined the board of San Francisco-based biotech Alector, a company that hopes …
astrazeneca_sign_sky

AstraZeneca’s Imfinzi immunotherapy combo fails to show benefit in lung cancer

November 16, 2018 Medical Communications, Research and Development AstraZeneca, Cancer, Imfinzi, lung cancer, pharma

AstraZeneca has revealed that its immunotherapy combo of Imfinzi (durvalumab) and tremelimumab failed to meet its primary endpoint in a …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Korea, NICE, Samsung, Theresa May, UK, brexit, politics, top 10

The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …
boehringer_biberach_germany_copy

Boehringer signs $300 million deal with Epizyme over epigenetic cancer treatment

November 16, 2018 Medical Communications Boehringer, Cancer, Epizyme, deal, oncology

German firm Boehringer Ingelheim and the Massachusetts-based biotech Epizyme have announced that they will collaborate on the development of novel, …
8655563196_1c0f83c447_z

United Therapeutics buys Arena’s hypertension drug ralinepag in deal worth $1.2 billion

November 16, 2018 Medical Communications Arena, PAH, United Therapeutics, deal sales, hypertension

US pharma firm United Therapeutics has agreed to by Arena Pharmaceuticals experimental pulmonary arterial hypertension (PAH) drug ralinepag in a …
ipsen-logo-big

Ipsen’s Cabometyx gains European approval in hepatocellular carcinoma

November 16, 2018 Medical Communications, Sales and Marketing Cabometyx, carcinoma, ipsen, pharma. European Commission

Ipsen’s Cabometyx has received approval from the European Commission for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular …
2tec9don_400x400

Dermavant appoint Todd Zavodnick as CEO

November 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roivant subsidiary Dermavant has appointed experienced pharma exec Todd Zavodnick as the company’s new CEO. The Rutger’s University graduate will …
psm_v46_d168_mesial_view_of_the_human_brain

Rising to the challenge of delivering therapeutic discovery for mental disorders

November 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NIHRm, Oxford, R&D, feature, investment, mental health

Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …
4768764591_9e4f7f0eb8_z

Phamaceutical trade lobby responds to Brexit deal

November 15, 2018 Business Services, Medical Communications, Research and Development ABPI, brexit, negotiations, pharma, politics

The Association of the British Pharmaceutical Industry (ABPI) has responded to Theresa May’s Brexit deal, after the government announced a …

Pfizer defeated in Britain’s highest court over Lyrica patent

November 15, 2018 Business Services, Medical Communications Legislation, Lyrica, Pfizer, court, pharma

American pharma firm Pfizer have lost in the final round of a protracted court battle over the patent on epilepsy …

Company tackling antimicrobial resistance appoint former Bayer VP as new managing director

November 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

British company Matoke Pharma have appointed former Bayer VP, Alan Westwood, as the firm’s new managing director, a role in …
diabetes-777001_960_720

3 in 4 UK diabetes patients suffer from mental health issues, says report

November 14, 2018 Medical Communications, Research and Development UK, World Diabetes Day, diabetes, pharma

To mark this year’s World Diabetes Day on 14 November, a new report has shed more light on the psychological …
michael_boyd

Gilead appoint Pfizer and AbbVie veteran as VP of governmental affairs

November 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

American antiviral drug specialist Gilead have appointed Pfizer and AbbVie veteran Michael Boyd as VP of government affairs and policy …
The Gateway to Local Adoption Series

Latest content